Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medico Intercontinental Ltd submitted the newspaper clippings of its unaudited financial results for Q1 FY26, which were approved by the Board on August 14, 2025 and published in English and Gujarati newspapers on August 15, 2025. On a standalone basis, total income from operations rose to ₹1,370.86 lakhs (vs ₹1,162.32 lakhs in Q1 FY25, ~18% YoY growth), while net profit after tax fell to ₹5.60 lakhs from ₹10.11 lakhs YoY, with EPS at ₹0.56. On a consolidated basis, revenue grew to ₹2,161.79 lakhs (vs ₹1,939.32 lakhs YoY), but the company swung to a net loss after tax of ₹248.80 lakhs, compared with a profit of ₹108.32 lakhs in Q1 FY25, resulting in a negative EPS of ₹(0.68).
The consolidated swing from profit to loss is a significant negative signal for shareholders, despite healthy revenue growth on both standalone and consolidated bases. The standalone profit after tax also dipped meaningfully, which could weigh on sentiment and the stock price in the near term.